Biotechnology · Healthcare
Board Member
2026-10-19–present
Board Member
Eloxx Pharmaceuticals, Inc. (ELOX)Equibles does not estimate personal net worth.
Get an email with a short summary when Eloxx Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELOX alertsGeno J. Germano is recorded as Board Member at Eloxx Pharmaceuticals, Inc. (ELOX) since October 19, 2026. Eloxx Pharmaceuticals, Inc. reported in an 8-K filed October 22, 2026 that Geno J. Germano was appointed director, effective October 19, 2026. Eloxx Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Eloxx Pharmaceuticals, Inc. includes Sumit Aggarwal (CEO and Board Member), Daniel Geffken (CFO and Chief Accounting Officer), Gary D. Rakers (CFO) and 7 others.
“On October 19, 2026, the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) increased the size of the Board from five to six directors and appointed Geno J. Germano to fill the newly created vacancy on the Board.”
2026-10-19–present
Biotechnology · Healthcare
Board Member
2026-10-19–present